top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
10th International Conference on the Development of Biomedical Engineering in Vietnam : Proceedings of BME 10, July 25-27, 2024, Phan Thiet, Vietnam: Healthcare Evolution Towards 5P Medicine in Low- and Middle-Income Countries Ecosystem - Volume 2: Tissue Engineering, Drug Discovery, and Health Informatics / / edited by Van Toi Vo, Thi-Hiep Nguyen, Binh Long Vong, Thi Thu Hien Pham, Ngoc Hoan Doan
10th International Conference on the Development of Biomedical Engineering in Vietnam : Proceedings of BME 10, July 25-27, 2024, Phan Thiet, Vietnam: Healthcare Evolution Towards 5P Medicine in Low- and Middle-Income Countries Ecosystem - Volume 2: Tissue Engineering, Drug Discovery, and Health Informatics / / edited by Van Toi Vo, Thi-Hiep Nguyen, Binh Long Vong, Thi Thu Hien Pham, Ngoc Hoan Doan
Autore Vo Van Toi
Edizione [1st ed. 2025.]
Pubbl/distr/stampa Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Descrizione fisica 1 online resource (1729 pages)
Disciplina 620.5
Altri autori (Persone) NguyễnThị Hiệp
LongVong Binh
PhamThi Thu Hien
DoanNgoc Hoan
Collana IFMBE Proceedings
Soggetto topico Nanotechnology
Medical informatics
Drug delivery systems
Nanoengineering
Health Informatics
Drug Delivery
ISBN 3-031-90197-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Investigation of Hydrogel-Based 3D Model on The Progression of Multicellular Breast Tumor Spheroids -- Fabrication of 3D printed structures based on Carboxymethyl Chitosan and Oxidized Polysaccharide Bio-inks -- A Review of Self-crosslinking Natural Polymeric Hydrogels as Promising Bioinks for Extrusion-based 3D Bioprinting in Cartilage Engineering -- Investigation of 3D-printed Scaffold Properties under CaCl2 Post-crosslinking.
Record Nr. UNINA-9911009335203321
Vo Van Toi  
Cham : , : Springer Nature Switzerland : , : Imprint : Springer, , 2025
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside
3D Printing of Pharmaceutical and Drug Delivery Devices : Progress from Bench to Bedside
Autore Lamprou Dimitrios A.
Edizione [First eddition.]
Pubbl/distr/stampa Newark : , : John Wiley & Sons, Incorporated, , 2024
Descrizione fisica 1 online resource (265 pages)
Disciplina 615.19
Altri autori (Persone) DouroumisDennis
QiSheng
Collana Advances in Pharmaceutical Technology Series
Soggetto topico Drug delivery systems
Pharmaceutical technology
ISBN 9781119836001
111983600X
9781119835981
1119835984
9781119835998
1119835992
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Intro -- 3D Printing of Pharmaceutical and Drug Delivery Devices -- Contents -- About the Editors -- List of Contributors -- Series Preface -- Preface -- 1 Materials for 3D Printing -- 1.1 Introduction -- 1.2 Material Processability Considerations for Pharmaceutical 3DP -- 1.2.1 Thermal Extrusion-Based 3D Printing -- 1.2.1.1 Thermal Considerations -- 1.2.1.2 Solubility Enhancement -- 1.2.1.3 Mechanical Considerations -- 1.2.2 Semi-Solid Extrusion 3DP -- 1.2.2.1 Rheological Considerations -- 1.2.2.2 Example Applications -- 1.2.3 Powder Bed Fusion 3D Printing -- 1.2.3.1 Powder Flowability Considerations -- 1.2.3.2 Powder Packing Density Considerations -- 1.2.3.3 Powder Energy Absorbance Considerations -- 1.2.4 Stereolithography 3D Printing -- 1.3 Classification of Common Materials Used in Pharmaceutical 3DP -- 1.3.1 Alcohol Derived Polymers -- 1.3.2 Eudragits -- 1.3.3 Other Polymers -- 1.3.4 Graft Polymers -- 1.3.5 Photocrosslinkable -- 1.3.6 Natural Materials -- 1.3.7 Lipid Materials -- 1.4 Conclusions and Future Perspectives -- References -- 2 The Use of Microstructure Design and 3D Printing for Tailored Drug Release -- 2.1 Introduction -- 2.2 3D-Printing Technologies -- 2.3 3D Design for Drug-Loaded Device -- 2.3.1 CAD Design-Based Design -- 2.3.2 Computational Software-Based Design -- 2.3.3 3D-Printing Parameter-Based Design -- 2.3.4 Polypills and Complex Designs -- 2.4 3D Designs Influence Drug Release -- 2.4.1 Controlling Drug Release -- 2.4.2 Modifying Drug Release -- 2.5 Challenges and Perspective -- References -- 3 3D Printing of Oral Solid Dosage Forms Using Selective Laser Sintering -- 3.1 Introduction -- 3.2 Operational Principles of Selective Laser Sintering -- 3.2.1 Manufacturing Challenges for SLS -- 3.2.2 Laser Selection and Scanning Speed -- 3.2.3 Powder Material Parameters -- 3.2.4 Powder Bed and Recoater Parameters.
3.3 3D-Printed Oral Dosages -- 3.4 Advantages of SLS -- 3.4.1 Printing Features -- 3.4.2 Control of Surface Properties -- 3.4.3 Printing of Complex Geometries -- 3.4.4 Using a Wide Range of Materials -- 3.4.5 Drug Loading and Dose Combinations -- 3.4.6 Personalised Dosage Forms -- 3.4.7 SLS Disadvantages -- 3.5 Conclusions -- References -- 4 3D Printing for Medical Device Applications -- 4.1 Introduction -- 4.2 3D Printers -- 4.2.1 SLA -- 4.2.2 FFF -- 4.2.3 Selective Laser Sintering (SLS) -- 4.3 Biomaterials for 3D-Printed Medical Devices -- 4.3.1 Bioresorbable Polymers -- 4.3.1.1 Synthetic Bioresorbable Polymers -- 4.3.1.2 Natural Bioresorbable Polymers -- 4.3.2 Non-Bioresorbable Polymers -- 4.3.3 Smart Polymers -- 4.3.4 Metal and Ceramic -- 4.4 3D-Printed Personalised Medical Devices -- 4.4.1 Vascular Repair Devices -- 4.4.2 Splints -- 4.4.3 Nerve Guidance Conduits -- 4.4.4 Tissue Engineering -- 4.4.5 3D Printing in Dentistry -- 4.4.6 3D-Printed Orthopaedic Devices -- 4.5 Regulatory -- 4.6 Future Perspectives -- References -- 5 3D Printed Implants for Long-Acting Drug Delivery -- 5.1 Introduction -- 5.2 Types of 3D-Printed Scaffolds -- 5.2.1 Implantable Scaffolds -- 5.2.1.1 Passive Implants -- 5.2.1.2 Active Implants -- 5.2.2 Injectable Scaffolds -- 5.2.3 Innovative 3D-Printed Scaffolds -- 5.3 Critical Parameters in Designing 3D-Printed Implantable Scaffolds -- 5.3.1 Structural Characteristics -- 5.3.1.1 Geometry of Implants -- 5.3.1.2 Porosity Properties and Pore Features -- 5.3.1.3 Surface Properties -- 5.3.2 Mechanical Properties -- 5.3.3 Biological and Physiological Parameters -- 5.3.3.1 Cellular Adhesion -- 5.3.3.2 Absorption and Degradation Rates -- 5.3.3.3 Biocompatibility Aspects -- 5.4 Critical Parameters in Selecting Materials for 3D-Printed Scaffolds -- 5.4.1 Materials Used in 3D-Printed Long-Acting Scaffolds -- 5.4.1.1 Natural Polymers.
5.4.1.2 Synthetic Polymers -- 5.4.1.3 Ceramics and Metals -- 5.4.1.4 Composites -- References -- 5.5 Manufacturing Techniques for Implantable Scaffolds -- 5.5.1 Hot-Melt Extrusion -- 5.5.2 Compression -- 5.5.3 Injection Moulding -- 5.5.4 Solvent Casting -- 5.5.5 3D Printing -- 5.5.6 Scale-Up in 3D-Printing Process for the Manufacturing of Scaffolds -- 5.6 Drug Release Mechanism of Long-Acting 3D-Printing Polymeric Implantable Systems -- 5.7 Outlining Regulatory Framework for 3D-Printed Implantable Scaffolds -- 5.7.1 Commercial Implantable Scaffolds -- 5.8 Conclusions -- References -- 6 Wound Dressings by 3D Printing -- 6.1 Wound Healing Process -- 6.1.1 Haemostasis/Coagulation -- 6.1.2 Inflammation -- 6.1.3 Proliferation -- 6.1.4 Re-epithelisation/Remodelling -- 6.1.5 Wound Classification -- 6.1.6 Wound Dressings -- 6.1.7 3D Printing -- 6.1.8 3D-Printed Dressings -- 6.2 Case Studies -- 6.3 Summary/Conclusions -- References -- 7 3D Printing of Hydrogels -- 7.1 Introduction -- 7.2 Applications of 3D-Printed Hydrogels -- 7.2.1 Tissue Engineering -- 7.2.2 Wound Healing -- 7.2.3 Drug Delivery -- 7.3 Types of Hydrogel Materials for 3D Printing -- 7.3.1 Natural Polymers -- 7.3.2 Synthetic Polymers -- 7.3.3 Natural-Synthetic Hybrid Polymers -- 7.3.4 Ionically Charged Polymers -- 7.3.5 Crosslinked Polymers -- 7.3.6 Method of Hydrogel Preparation -- 7.4 3D Printing Techniques for Hydrogels -- 7.4.1 Laser-Based 3D Printing -- 7.4.1.1 Stereolithography -- 7.4.1.2 Two-Photon Polymerisation -- 7.4.1.3 Laser-Induced Forward Transfer -- 7.4.2 Extrusion-Based Printing -- 7.4.3 Inkjet-Based Printing -- 7.5 Printability and Printing Parameters -- 7.5.1 Bioink Design -- 7.5.1.1 Materials Selection, Concentration and Viscosity -- 7.5.1.2 Rheological Properties -- 7.5.1.3 Shear-Thinning -- 7.5.1.4 Viscoelasticity and Yield Stress -- 7.5.1.5 Cell Encapsulation.
7.5.2 Crosslinking Techniques -- 7.5.2.1 Thermal Crosslinking -- 7.5.2.2 Physical Ionic Crosslinking -- 7.5.2.3 Chemical Crosslinking -- 7.5.2.4 Photocrosslinking -- 7.5.3 3D Printing Parameters -- 7.5.3.1 Temperature -- 7.5.3.2 Pressure -- 7.5.3.3 Speed -- 7.6 Clinical Translation -- 7.6.1 Regulatory Considerations -- 7.6.2 Manufacturing Considerations -- 7.6.3 Limitations and Future Direction -- 7.7 Conclusions -- References -- 8 Analytical Characterisation of 3D-Printed Medicines -- 8.1 Introduction -- 8.2 Preformulation -- 8.2.1 Thermal Analysis -- 8.2.2 X-Ray Powder Diffraction (XRPD) -- 8.2.3 Infrared Spectroscopy -- 8.2.4 Hot-Stage Microscopy (HSM) -- 8.2.5 Customizsd Sample Preparation for the Preformulation Protocol -- 8.3 In-Process Characterisations -- 8.3.1 Mechanical Analysis -- 8.3.2 Rheological Analysis -- 8.3.3 Drug Characterisation -- 8.4 Final Product -- 8.4.1 Morphological Analysis -- 8.4.2 X-Ray Computed Microtomography (XμCT) -- 8.4.3 Terahertz Pulsed Imaging (TPI) -- 8.4.4 Mercury Porosimetry -- 8.4.5 Helium Pycnometry -- 8.5 Conclusions -- References -- 9 Adoption of 3D Printing in Pharmaceutical Industry -- 9.1 Partnering and Growing -- 9.2 Regulatory Strategy -- 9.2.1 Product Development -- 9.2.2 Manufacturing -- 9.3 Business Model -- 9.3.1 In-House Pipeline Products -- 9.3.2 Co-Development -- 9.4 Regulatory Strategy -- 9.5 Partnering and Growing -- 9.6 Business Model and Strategy -- 9.6.1 Closing Remarks -- References -- 10 Clinical Benefits of 3D Printing in Healthcare -- 10.1 Introduction -- 10.2 3D Printing Technologies -- 10.2.1 Binder Jetting -- 10.2.2 Vat Photopolymerization -- 10.2.3 Powder Bed Fusion -- 10.2.4 Material Jetting -- 10.2.5 Material Extrusion -- 10.2.5.1 Fused Deposition Modelling -- 10.2.5.2 Semi-Solid Extrusion -- 10.2.5.3 Direct Powder Extrusion -- 10.3 Preclinical Applications of 3D Printing.
10.3.1 Immediate and Modified Release Oral Printlets -- 10.3.2 3D-Printed Drug Delivery Devices for Other Routes of Administration -- 10.4 Clinical Applications of 3D Printing -- 10.4.1 Personalised Medications -- 10.4.2 Improved Acceptability and Medication Compliance -- 10.4.2.1 Paediatric Patients -- 10.4.2.2 Adult and Geriatric Patients -- 10.4.3 Mass Manufacturing -- 10.4.4 Decentralised On-Demand Fabrication -- 10.4.5 Veterinary Applications -- 10.5 Challenges, Regulatory View and Future Applications -- 10.6 Conclusion -- References -- 11 Regulatory Aspects of 3D-Printed Medicinal Products -- 11.1 Introduction -- 11.2 Current Regulatory Framework -- 11.3 Quality Aspects of 3D-Printed Medicinal Products -- 11.4 3D-Printed Paediatric Medicinal Products -- 11.5 3D-Printed Systems With Tailored Release Profiles -- 11.6 Conclusions -- Disclaimer -- References -- Index -- EULA.
Record Nr. UNINA-9910876527503321
Lamprou Dimitrios A.  
Newark : , : John Wiley & Sons, Incorporated, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems / Deepak Kaushik, Ravinder Verma
A Comprehensive Text Book on Self-emulsifying Drug Delivery Systems / Deepak Kaushik, Ravinder Verma
Autore Kaushik Deepak
Edizione [1st ed.]
Pubbl/distr/stampa Singapore : , : Bentham Science Publishers, , 2021
Descrizione fisica 1 online resource (211 pages)
Disciplina 615.6
Altri autori (Persone) VermaRavinder
Soggetto topico Drug delivery systems
Excipients
ISBN 9789814998000
9814998001
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Different Methodologies for Improving Solubility and Bioavailability -- Ravinder Verma1, Deepak Kaushik1,*, Ritu Kaushik1 and Vandana Singh1 -- INTRODUCTION -- DIFFICULTIES IN THE ORAL DRUG DELIVERY -- ORAL BIOAVAILABILITY -- REASON FOR POOR ORAL BIOAVAILABILITY -- DRUG SOLUBILITY -- REQUIREMENT FOR SOLUBILITY IMPROVEMENT -- APPROACHES TO ENHANCE ORAL BIOAVAILABILITY -- VARIOUS TECHNIQUES FOR IMPROVING BIOAVAILABILITY -- Salt Formation -- Cyclodextrins Based Complexes -- TECHNIQUES OF COMPLEXATION -- Kneading Technique -- Co-precipitation Technique -- Spray Drying -- NOVEL FORMULATION APPROACHES FOR BIOAVAILABILITY ENHANCEMENT -- Polymeric Micelles -- Liposomes -- Solid Lipid Nanoparticles (SLNs) -- Dendrimers -- PARTICLE SIZE REDUCTION -- Strategies -- Mechanical Micronization -- Jet Milling -- Ball Milling -- High-Pressure Homogenization -- Engineered Particle Size Control -- Strategies of Cryogenic Method -- Cryogenic Method -- Spray Freezing onto Cryogenic Fluids -- Spray Freezing into Cryogenic Liquids -- Spray Freezing into Vapor over Liquid -- Ultra-rapid Freezing (URF) -- Crystal Engineering -- Co-crystals -- Nanoparticles -- Solid Dispersion (SD) -- TECHNIQUES OF SOLID DISPERSION -- Fusion (melt) Technique -- Solvent Technique -- Dropping Technique -- Co-crystal Formation -- Supercritical Fluid Recrystallization (SCF) -- Sonocrystallisation -- Liquisolid Technique -- Formation of Inclusion Complex -- Kneading Method -- Lyophilization/Freeze-Drying Technique -- Microwave Irradiation Method -- Self-micro Emulsifying Drug Delivery Systems (SMEDDS) -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Introduction to Lipid-Based Drug Delivery Systems for Oral Delivery.
Deepak Kaushik1,*, Ravinder Verma1, Rekha Rao2 and Prerna Kaushik1 -- LIPID-BASED DRUG DELIVERY SYSTEM (LBDDS) -- A Perfect Oral Lipid-Based Dosage Forms Must Meet Various Aspects -- Benefits of LBDDS -- LIPID FORMULATION CLASSIFICATION SYSTEM -- Four Types of LFCS -- Classification System for Lipid Formulations -- APPROACHES IN LBDDS -- Emulsion -- Microemulsion -- Nanoemulsion -- Liposomes -- Solid Lipid Nanoparticles -- Niosomes -- Lipospheres -- Ethosomes -- Self-emulsifying Drug Delivery System (SEDDS) -- SMEDDS AND SNEDDS -- Nano Lipid Carriers (NLCs) -- FORMULATION DEVELOPMENT AND CHARACTERIZATION -- Parameters to be Judged for the Development of the Formulation -- GUIDELINES FOR DESIGNING OF LBFS -- FORMULATION FACTORS INFLUENCING BIOAVAILABILITY OF DRUGS FROM LBDDS -- Lipid Digestion -- Mean Droplet Size of Emulsion -- Hydrophobic Nature of API -- Chemism of Lipids -- Ingredient Selection for LBFs -- ANALYSIS OF EXCIPIENTS IN LBDDS -- Chemical Analysis -- Physical Analysis -- Analysis of Physiological Effects of Ingredients -- MECHANISM OF LIPID-BASED DRUG DELIVERY SYSTEM -- MECHANISMS FOLLOWED BY LBDDS FOR UPGRADING THE RETENTION -- Improved Rate of Dissolution/Solubilization -- Extension of Gastric Retention Time -- Stimulation of Lymphatic Transport -- Change in the Physical Barrier Role of GI Tract -- Change in Biochemical Hindrance Capacity of GI Tract -- Impact of Oils on Retention -- Digestion of Lipids -- Retention of Lipids -- Drug Assimilation through the Intestinal Lymphatic System -- THERAPEUTIC EQUIVALENCE OF LBDDS -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Self-Micro Emulsifying Drug Delivery Systems and their Applications -- Deepak Kaushik1,*, Ravinder Verma1 and Parijat Pandey2 -- LIPID-BASED DRUG DELIVERY SYSTEMS -- SELF-MICRO EMULSIFYING DRUG DELIVERY SYSTEM.
History of Micro-emulsions -- Benefits -- Drawbacks -- Formulation -- Finding Solubility of the Drug in Various Ingredients -- Selection of Ingredients -- Construction of Ternary Phase Diagram -- Preparation and Evaluation -- Selection of Appropriate Medicament Candidate -- Role of SMEDDS for BCS Class Drugs -- Mechanism of Self-emulsification -- APPLICATIONS OF SMEDDS -- Self-microemulsions in Pharmaceutical -- Cosmetics Agents as Self-microemulsions -- Analytical Purpose of Self-microemulsions -- Self-microemulsions for Biotechnology -- Use of Microemulsions in Enzymatic Reactions -- Microemulsion for Immobilization of Protein -- Bioseparations by Microemulsions -- Microemulsions as Chemical Sensor Materials -- Microemulsions as Microreactors and Blood Substitutes -- DOSAGE FORM OF SMEDDS -- Oral Route -- SE Capsules -- SE Sustained/Controlled Release -- SE Pellets -- SE Solid Dispersions -- Topical Delivery -- Ocular Delivery -- Parental Delivery -- Nasal Delivery -- Drug Targeting -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Components of Self-Microemulsifying Drug Delivery System -- Ravinder Verma1, Deepak Kaushik1,*, Manish Kumar2 and Deepak Parmar3 -- SELECTION OF INGREDIENTS IN SEFS -- Hydrophilic-Lipophilic Balance (HLB) -- Partition Coefficient -- IDENTIFICATION OF SUITABLE DRUG CANDIDATE FOR SEDDS -- COMPONENTS OF SMEDDS -- Lipids/Oils -- Selection of Oil -- Role -- Lipids in Oral Drug delivery -- Methods of Controlled Discharge with Lipids -- Surfactants -- Mechanism -- Classification -- Classification Based on Hydrophilic-Lipophilic Balance (HLB) Number- -- Lipophilic Surfactants -- Hydrophilic Surfactants -- Classification Based on the Composition of Counter-ion- -- Monoatomic/Inorganic -- Polyatomic/Organic -- Role -- Co-surfactants -- Other Components -- Consistency Builder.
Enzyme Inhibitors -- IMPACT OF INGREDIENTS ON GLOBULES SIZE -- MULTI-FUNCTIONAL EXCIPIENT USED IN SEDDS/SMEDDS -- Relation of HLB with the Solubility -- Requirement of HLB- Why HLB Required? -- HLB Calculation -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Lymphatic Transport of Lipid-Based Drug Delivery System -- Ravinder Verma1, Deepak Kaushik1,*, Beena Kumari2 and Anurag Khatkar1 -- LYMPHATIC TRANSPORT -- BENEFITS -- Approaches to Upgrade Lymphatic Transportation of the Drug -- Favorable Circumstances of Intestinal Transportation of Drugs -- Parameters Affecting Lymphatic Transportation of LBFs -- Size of Globules -- Charge on Drug -- Molecular Weight of Drug -- Lipophilicity -- Lipid Solubility and Partition Coefficient of Drugs -- Type of Lipid -- Concentration of Surfactant -- VARIOUS MODELS UTILIZED FOR INVESTIGATION OF DRUG TRANSPORTATION VIA LYMPHATIC SYSTEM -- Models for In Vivo -- Models for In Vitro -- Evaluation of Animal Model for Lymphatic Transport -- Lack of Effective In Vitro Tests -- LIMITED LYMPHATIC UPTAKE OF LBDDS -- In Vivo Studies based on Dispersed Formulations for Lymphatic Assimilation -- Impact of Lipidic Excipients on Lymphatic Transport -- Impact Food on Self-emulsification of LBFs -- Reduction of Food Effect -- Biopharmaceutical Issues -- Specificity -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Advantages, Marketed Formulations and Evaluation Parameters of SMEDDS -- Deepak Kaushik1,*, Ravinder Verma1, Vineet Mittal1 and Deepika Purohit2 -- APPLICATIONS OF SMEDDS -- Upgrading Solubility and Bioavailability -- Protection Against Biodegradation -- Low Cost of Production and Ease of Scale-up -- Diminishment of Inter/intra-subject Variability and Food Effects -- Capability to Convey Peptides that are Liable to Enzymatic Hydrolysis in GIT.
No Impact of Lipid Digestion Mechanism -- Improved Drug Loading Capacity -- Supersaturable SMEDDS (s-SMEDDS) -- MECHANISM OF SELF-EMULSIFICATION -- FACTORS INFLUENCING SMEDDS -- Nature and Amount of the Drug -- Polarity of the Lipophilic Phase -- Solubility Equailibrium -- Charge on Droplet of Emulsion -- EVALUATION PARAMETERS -- Globule Size Estimation -- Small-angle Neutron Scattering -- Refractive Index and Percent Transmission -- Robustness Dilution -- Zeta Potential Estimation -- Electroconductivity Study -- Turbidimetric Assessment -- Effect of Dilution at various pH -- Impact of Temperature -- Determination of Viscosity -- Cloud Point Estimation -- Centrifugation Stability Evaluation -- Dye Solubilization Test -- TEM Analysis -- Dispersibility Test -- Impact of Drug Loading on Droplet Size -- Drug Content Estimation -- In Vitro Lipolysis -- In Vitro Drug Release Assessment -- Thermodynamic Stability Study -- Permeability Study -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Solid-SMEDDS: Techniques of Solidification and Recent Advancements -- Ravinder Verma1, Deepak Kaushik1, Parijat Pandey2,* and Pawan Jalwal2 -- SOLID SELF-EMULSIFYING DRUG DELIVERY SYSTEM -- Solidification Methods for Altering Semisolid/Liquid Self-emulsifying Drug Delivery System to S-SEDDS -- Spray Drying -- Spray Cooling -- Adsorption to Solid Carriers -- Melt Granulation -- Melt Extrusion/Extrusion Spheronization -- Supercritical Liquid-based Technique -- Issues Related to the Solidification Strategies -- Ways to Deal with the Problems of Solidification Strategies -- Various Advancements of S-SMEDDS -- SE Tablets -- SE Sustained/Controlled-Release Tablets -- SE Capsules -- SE Solid Dispersions -- SE Dry Emulsions -- SE Beads -- Self-emulsifying Pellets (SE pellets) -- SE Sustained-release Microspheres -- SE Nanoparticles.
SE Implants.
Record Nr. UNINA-9911117240903321
Kaushik Deepak  
Singapore : , : Bentham Science Publishers, , 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The AAPS journal
The AAPS journal
Pubbl/distr/stampa Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003-
Disciplina 615
Soggetto topico Drug delivery systems
Pharmaceutical technology
Drugs - Administration
Pharmaceutical Preparations
Drug Therapy
Technology, Pharmaceutical
Médicaments - Administration - Dispositifs
Techniques pharmaceutiques
Médicaments - Administration
Tecnologia farmacèutica
Dispositius d'administració de medicaments
Formes farmacèutiques
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
Revistes electròniques.
Soggetto non controllato Pharmacy, Therapeutics, & Pharmacology
ISSN 1550-7416
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti AAPSJ
American Association of Pharmaceutical Scientists journal
Record Nr. UNISA-996216608703316
Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003-
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
The AAPS journal
The AAPS journal
Pubbl/distr/stampa Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003-
Disciplina 615
Soggetto topico Drug delivery systems
Pharmaceutical technology
Drugs - Administration
Pharmaceutical Preparations
Drug Therapy
Technology, Pharmaceutical
Médicaments - Administration - Dispositifs
Techniques pharmaceutiques
Médicaments - Administration
Tecnologia farmacèutica
Dispositius d'administració de medicaments
Formes farmacèutiques
Soggetto genere / forma Periodical
Fulltext
Periodicals.
Revistes electròniques.
ISSN 1550-7416
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti AAPSJ
American Association of Pharmaceutical Scientists journal
Record Nr. UNINA-9910143514203321
Arlington, Va., USA, : American Association of Pharmaceutical Scientists, 2003-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
AAPS PharmSci
AAPS PharmSci
Pubbl/distr/stampa Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004
Disciplina 615
Soggetto topico Drug delivery systems
Pharmaceutical technology
Drugs - Administration
Pharmaceutical Preparations
Drug Therapy
Technology, Pharmaceutical
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
ISSN 1522-1059
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNISA-996208575503316
Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004
Materiale a stampa
Lo trovi qui: Univ. di Salerno
Opac: Controlla la disponibilità qui
AAPS PharmSci
AAPS PharmSci
Pubbl/distr/stampa Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004
Disciplina 615
Soggetto topico Drug delivery systems
Pharmaceutical technology
Drugs - Administration
Drugs
Chemotherapy
Pharmaceutical Preparations
Drug Therapy
Technology, Pharmaceutical
Médicaments - Administration - Dispositifs
Techniques pharmaceutiques
Médicaments - Administration
Systèmes d'administration de médicaments
Médicaments
Chimiothérapie
44.42 pharmacy, pharmaceuticals
Soggetto genere / forma Periodical
Fulltext
Internet Resources.
Periodicals.
ISSN 1522-1059
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Altri titoli varianti American Association of Pharmaceutical Scientists PharmSci
PharmSci
Record Nr. UNINA-9910135383503321
Alexandria, VA, : American Association of Pharmaceutical Scientists, [1999?]-2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Adaptive Dynamic Programming : For Chemotherapy Drug Delivery / / by Jiayue Sun, Shun Xu, Yang Liu, Huaguang Zhang
Adaptive Dynamic Programming : For Chemotherapy Drug Delivery / / by Jiayue Sun, Shun Xu, Yang Liu, Huaguang Zhang
Autore Sun Jiayue
Edizione [1st ed. 2024.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024
Descrizione fisica 1 online resource (XV, 135 p. 40 illus., 38 illus. in color.)
Disciplina 629.8
Collana Intelligent Technologies and Robotics Series
Soggetto topico Automatic control
Robotics
Automation
Drug delivery systems
Control, Robotics, Automation
Drug Delivery
ISBN 981-9959-29-2
Classificazione SCI010000TEC004000
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Preface -- Acknowledgements -- Chapter1 Introduction -- Chapter 2 Neural Networks-Based Immune Optimization Regulation Using Adaptive Dynamic Programming -- Chapter 3 Optimal Regulation Strategy for Nonzero-Sum Games of the Immune System Using Adaptive Dynamic Programming -- Chapter 4 Evolutionary Dynamics Optimal Research-Oriented Tumor Immunity Architecture -- Chapter 5 N-Level Hierarchy-Based Optimal Control to Develop Therapeutic Strategies for Ecological Evolutionary Dynamics Systems -- Chapter 6 Combination Therapy-Based Adaptive Control for Organism Using Medicine Dosage Regulation Mechanism.-Chapter 7 Adaptive Virotherapy Strategy for Organism with Constrained Input Using Medicine Dosage Regulation Mechanism -- References.
Record Nr. UNINA-9910745587603321
Sun Jiayue  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2024
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Additive Manufacturing in Pharmaceuticals / / edited by Subham Banerjee
Additive Manufacturing in Pharmaceuticals / / edited by Subham Banerjee
Autore Banerjee Subham
Edizione [1st ed. 2023.]
Pubbl/distr/stampa Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Descrizione fisica 1 online resource (378 pages)
Disciplina 615.6
Collana Biomedical and Life Sciences Series
Soggetto topico Pharmaceutical chemistry
Drug delivery systems
Pharmacology
Pharmaceutics
Drug Delivery
Tecnologia farmacèutica
Impressió 3D
Medicaments
Soggetto genere / forma Llibres electrònics
ISBN 9789819924042
9819924049
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto 1. History and Present Scenario of Additive Manufacturing in Pharmaceuticals -- 2. Fused deposition modeling (FDM) of Pharmaceuticals -- 3. Stereolithography (SLA) in Pharmaceuticals -- 4. Selective Laser Sintering (SLS) In Pharmaceuticals -- 5. Semi-solid Extrusion (SSE) in Pharmaceuticals -- 6. Inkjet and Binder Jet Printing in Pharmaceuticals -- 7. 4D printing: The next dimension of healthcare in cancer research -- 8. 4D Printing in Pharmaceuticals -- 9. Bioprinting in Pharmaceuticals -- 10. Regulatory Perspective of Additive Manufacturing in the Field of Pharmaceuticals -- 11. Machine Learning in Additive Manufacturing of Pharmaceuticals. .
Record Nr. UNINA-9910746101003321
Banerjee Subham  
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The ADME Encyclopedia : A Comprehensive Guide on Biopharmacy and Pharmacokinetics / / edited by Alan Talevi
The ADME Encyclopedia : A Comprehensive Guide on Biopharmacy and Pharmacokinetics / / edited by Alan Talevi
Edizione [1st ed. 2022.]
Pubbl/distr/stampa Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022
Descrizione fisica 1 online resource (1209 pages)
Disciplina 615.7
Collana Biomedical and Life Sciences Series
Soggetto topico Pharmacology
Pharmaceutical chemistry
Drug delivery systems
Pharmaceutics
Drug Delivery
Farmacocinètica
Soggetto genere / forma Enciclopèdies electròniques
Llibres electrònics
ISBN 9783030848606
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Drug Dissolution and Drug Release -- Drug Absorption -- Drug Distribution -- Drug Metabolism -- Drug Excretion -- Routes of Administration -- next Generation Drug Delivery Systems -- Pharmacogenomics -- Bioavailability and Bioequivalence -- Biopharmaceutical Drug Products -- Drug-Drug and Food-Drug Interactions -- In vitro and In silico ADME Predictions -- Drug Transporters -- Non-linear Pharmacokinetics -- Time Dependent Pharmacokinetics -- Pharmacometrics and Physiological Models.
Record Nr. UNINA-9910578693903321
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui